脂质特征、降脂药物靶基因与子宫内膜异位症的基因关联
本研究采用双向孟德尔随机化探讨脂质特征与子宫内膜异位症的因果关系,并利用药物靶点孟德尔随机化探索降脂药物靶基因。结果提示子宫内膜异位症与血脂异常存在潜在双向因果关联,PCSK9、APOB和ANGPTL3的遗传模拟与早期子宫内膜异位症风险相关。
要点
- 遗传预测的甘油三酯、LDL-C与子宫内膜异位症风险正相关,HDL-C、载脂蛋白A负相关。
- 反向孟德尔随机化显示遗传预测的子宫内膜异位症与甘油三酯浓度因果相关。
- PCSK9、APOB和ANGPTL3遗传模拟与1-2期子宫内膜异位症风险显著相关。
核心结论
- 子宫内膜异位症与血脂异常之间可能存在双向因果关联。
- PCSK9、APOB和ANGPTL3的遗传模拟与早期子宫内膜异位症风险相关。
- 开发降脂药物治疗子宫内膜异位症具有潜在临床意义。
研究设计与样本
- 采用双向孟德尔随机化研究脂质特征与子宫内膜异位症的因果关联。
- 采用药物靶点孟德尔随机化探索治疗子宫内膜异位症的潜在药物靶基因。
主要发现
- 遗传预测的甘油三酯浓度与子宫内膜异位症因果相关(OR 1.15,95%CI 1.08-1.23)。
- 遗传预测的高密度脂蛋白胆固醇浓度与子宫内膜异位症因果相关(OR 0.87,95%CI 0.81-0.94)。
- 遗传预测的低密度脂蛋白胆固醇浓度与子宫内膜异位症因果相关(OR 1.20,95%CI 1.06-1.34)。
- 遗传预测的载脂蛋白A浓度与子宫内膜异位症因果相关(OR 0.90,95%CI 0.83-0.96)。
- 反向孟德尔随机化显示遗传预测的子宫内膜异位症与甘油三酯浓度因果相关(OR 1.02,95%CI 1.01-1.02)。
关键数值与推荐
- PCSK9遗传模拟与子宫内膜异位症1-2期风险显著相关(OR 1.40,95%CI 1.13-1.72)。
- APOB遗传模拟与子宫内膜异位症1-2期风险显著相关(OR 1.49,95%CI 1.21-1.86)。
- ANGPTL3遗传模拟与子宫内膜异位症1-2期风险显著相关(OR 1.57,95%CI 1.14-2.16)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does the observed correlation between dyslipidaemia and endometriosis indicate a bidirectional causal association? DESIGN: Bidirectional Mendelian randomization was used to investigate the causal association between lipid traits and endometriosis. Drug-target Mendelian randomization was used to explore potential drug-target genes for managing endometriosis. In cases where lipid-mediated effects via specific drug targets were significant, aggregate analyses, such as summary-data-based Mendelian randomization and colocalization methods, were introduced to validate the outcomes. Mediation analyses supplemented these evaluations. RESULTS: The bidirectional Mendelian randomization results suggested that genetically predicted triglyceride (OR 1.15, 95% CI 1.08-1.23), high-density lipoprotein cholesterol (OR 0.87, 95% CI 0.81-0.94), low-density lipoprotein cholesterol (OR 1.20, 95% CI 1.06-1.34) and apolipoprotein A (OR 0.90, 95% CI 0.83-0.96) concentrations were causally associated with endometriosis. Reverse Mendelian randomization results revealed that genetically proxied endometriosis was causally associated with triglyceride concentration (OR 1.02, 95% CI 1.01-1.02). In drug-target Mendelian randomization, genetic mimicry in proprotein convertase subtilisin/kexin type 9 (PCSK9) (OR 1.40, 95% CI 1.13-1.72), apolipoprotein B (APOB) (OR 1.49, 95% CI 1.21-1.86) and angiopoietin-related protein 3 (ANGPTL3) (OR 1.57, 95% CI 1.14-2.16) was significantly associated with the risk of endometriosis stages 1-2. CONCLUSION: There is a potential bidirectional causal association between endometriosis and dyslipidaemia. Genetic mimicry of PCSK9, APOB and ANGPTL3 is associated with the risk of early-stage endometriosis. The development of lipid-lowering drugs to treat endometriosis is of potential clinical interest.
引用
- Zhou G, Ren J, Huang Q, et al. Gene associations of lipid traits, lipid-lowering drug-target genes and endometriosis. Reprod Biomed Online. 2024. PMID: 38657291. doi:10.1016/j.rbmo.2024.103856
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。